Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment

A nanomedicinal composition, comprising:

• a nanocarrier comprising:
• a metal organic framework which is a zeolitic imidazolate framework, and
• a porous silicate and/or aluminosilicate matrix, wherein the porous silicate and/or aluminosilicate matrix is present in an amount of 1 to 20 wt % based on a total weight of the nanocarrier;
• and
• an antioxidant disposed in the pores and/or on a surface of the nanocarrier,
• wherein the antioxidant is Resveratrol in phenolic form or Curcumin in phenolic form;
• wherein the nanocarrier has a surface area of 225 to 750 m2/g, a pore volume of 0.25 to 0.85 cm3/g, and a mean pore size of 2 to 10 nm,
• wherein said nanomedicinal composition reduces the viability of Blastocystis organisms by at least 75% when they are exposed to 100 to 1000 μg/mL of the nanomedicinal composition for 24 hours in vitro.